Is a complete TLV/IMED research report available?

No complete published report is available for tlv/IMED (TLV/IMED) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

TLV/IMED (TLV/IMED)

Tel Aviv Stock Exchange: TLV/IMED · ILA

ILA 94.2

+0.40 (+0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TLV/IMED analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.8M
Revenue (ttm)	720.5K
Net income (ttm)	-612.1K
EPS (ttm)	-ILA 0.15
Shares out	4M
Volume	8,500
Beta	0.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 720.5K
Net income (ttm): -612.1K
EPS (ttm): -ILA 0.15
Market cap: 3.8M

All TLV/IMED indicators

Market & fundamental data

Available fields

155

Groups with data

Currency

USD

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	80
Employees Change	10%
Employees Change Percent	14.29
Enterprise value	ILA -5.4M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Health Information Services
Isin	IL0011712309
Last refreshed	2026-08-02
Market cap	ILA 3.8M
Price	ILA 94.2
Price currency	ILA
Rev Per Employee	9,006.1x
Sector	Healthcare
Sector PE	62.31
Sector PE Fwd	12.59
Sic	7370
Symbol	tlv/IMED
Website	https://www.infinitymedical.co.il/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.1%
P/B ratio	0.15x
P/S ratio	5.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-188.5%
Gross margin	100%
Gross Profit	ILA 720,488
Gross Profit Growth	451.22%
Gross Profit Growth3 Y	4.16%
Net Income	ILA -612,096
Net Income Growth Years	2%
Pretax Margin	-84.96%
Profit Margin	-84.96%
Profit Per Employee	ILA -7,651
ROA	-3.39
Roa5y	-5.67
ROCE	-5.42
ROE	-2.5
Roe5y	-9.2
ROIC	-3.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.4%
Cagr3y	26.94%
Cagr5y	-14.6%
EPS Growth Years	2
Revenue Growth	451.22x
Revenue Growth Years	0x
Revenue Growth3 Y	4.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.03
Assets	ILA 25.6M
Cash	ILA 9.2M
Current Assets	ILA 8.9M
Current Liabilities	ILA 572,774
Debt	ILA 0
Equity	ILA 25M
Liabilities	ILA 596,156
Long Term Assets	ILA 16.8M
Long Term Liabilities	ILA 23,382
Net Cash	ILA 9.2M
Net Cash By Market Cap	ILA 242
Net Cash Growth	226.13%
Net Debt Equity	ILA -0.37
Tangible Book Value	ILA 25M
Tangible Book Value Per Share	ILA 6.21
WACC	5.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.47
Net Working Capital	ILA -564,276
Quick ratio	15.47
Working Capital	ILA 8.6M
Working Capital Turnover	ILA 0.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.39%
200-day SMA	118
3Y total return	104.56%
50-day SMA	116.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-54.58%
All Time High	1,180
All Time High Change	-92.02%
All Time High Date	2021-01-05
All Time Low	52.7
All Time Low Change	78.75%
All Time Low Date	2025-03-31
ATR	4.76
Beta	0.25
Beta1y	0.14
Beta2y	-0.25
Ch YTD	-22.72
High	109.5
High52	184.8
High52 Date	2025-07-27
High52ch	-49.03%
Low	93.6
Low52	91.5
Low52 Date	2026-07-21
Low52ch	2.95%
Ma50ch	-18.87%
Price vs 200-day SMA	-20.19%
RSI	27.95
RSI Monthly	38.42
RSI Weekly	0
Sharpe ratio	1.26x
Sortino ratio	3.62
Total Return	1.76%
Tr YTD	-22.72
Tr1m	-19.76%
Tr1w	-13.89%
Tr3m	-17.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -1.4M
Operating margin	-188.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Insiders	80.51%
Shares Institutions	19.98%
Shares Out	4,035,000
Shares Qo Q	6.39%
Shares Yo Y	-1.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	14,847.1x
Bv Per Share	6.21
Ch1m	-19.76
Ch1w	-13.89
Ch1y	-29.39
Ch3m	-17.37
Ch3y	-17.94
Ch5y	-81.78
Ch6m	-19.14
Change	0.43%
Change From Open	-13.97
Close	93.8
Days Gap	16.74
Dollar Volume	800,700
Earnings Date	2026-08-28
EBIT	ILA -1.4M
EPS	ILA -0.15
F Score	2
Financing CF	1,632,256
Fiscal Year End	December
Founded	2,020
Investing CF	5,824,476
Is Primary Listing	1
Last Earnings Date	2025-11-26
Last Report Date	2025-12-31
Ma150	126.9
Ma150ch	-25.75%
Ma20	111.9
Ma20ch	-15.83%
Net CF	6,372,812
Next Earnings Date	2026-08-28
Open	109.5
Position In Range	3.77
Price Date	2026-07-22
Ptbv Ratio	0.15
Relative Volume	0.57x
Revenue	720,488x
Tr6m	-19.14%
Volume	8,500
Z Score	4.04

TLV/IMED (TLV/IMED)

Coverage state: Market snapshot only — no published research

Generate the first TLV/IMED analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TLV/IMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TLV/IMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TLV/IMED

Frequently asked questions